Serotonin–norepinephrine releasing agent
A serotonin–norepinephrine releasing agent (SNRA) is a type of drug which induces the release of serotonin and norepinephrine (and epinephrine) in the body and/or brain.
Only a few SNRAs are known, examples of which include norfenfluramine, (R)-MDMA, MBDB, and MDAI. Fenfluramine produces norfenfluramine as a major active metabolite and hence is an SNRA similarly. It was formerly used as an appetite suppressant for the treatment of obesity. (R)-MDMA, MBDB, and MDAI are entactogens. Dexfenfluramine is also an SNRA.[1]
A closely related type of drug is a serotonin–norepinephrine reuptake inhibitor (SNRI).
Mechanism of action
[edit]See also
[edit]- Monoamine releasing agent
- Serotonin releasing agent
- Norepinephrine releasing agent
- Serotonin–dopamine releasing agent
- Serotonin–norepinephrine–dopamine releasing agent
References
[edit]- ^ Dyballa, Sylvia; Miñana, Rafael; Rubio-Brotons, Maria; Cornet, Carles; Pederzani, Tiziana; Escaramis, Georgia; Garcia-Serna, Ricard; Mestres, Jordi; Terriente, Javier (2019-10-01). "Comparison of Zebrafish Larvae and hiPSC Cardiomyocytes for Predicting Drug-Induced Cardiotoxicity in Humans". Toxicological Sciences. 171 (2): 283–295. doi:10.1093/toxsci/kfz165. ISSN 1096-6080. PMC 6760275. PMID 31359052.